key: cord-0766111-z3h1znxe
authors: Gonzalez-Plaza, Elena; Bellart, Jordi; Arranz, Ángela; Luján-Barroso, Leila; Crespo Mirasol, Esther; Seguranyes, Gloria
title: Effectiveness of a Step Counter Smartband and Midwife Counseling Intervention on Gestational Weight Gain and Physical Activity in Pregnant Women With Obesity (Pas and Pes Study): Randomized Controlled Trial
date: 2022-02-15
journal: JMIR Mhealth Uhealth
DOI: 10.2196/28886
sha: 3ba2aa9832339941fc8988e0cf8b7af2e85f585a
doc_id: 766111
cord_uid: z3h1znxe

BACKGROUND: Women who are pregnant and have obesity and excessive gestational weight gain (GWG) present a higher risk of maternal and perinatal complications. The use of mobile apps and a wristband during pregnancy may contribute to promoting healthy lifestyles and, thus, improving maternal and neonatal health. OBJECTIVE: This study aims to evaluate the effectiveness of a complex digital health intervention, using a smartband and app with midwife counseling, on GWG and physical activity (PA) in women who are pregnant and have obesity and analyze its impact on maternal and perinatal outcomes. In addition, we aim to study the frequency of use, usability, and satisfaction with the mobile apps used by the women in the intervention group. METHODS: A parallel, 2-arm, randomized controlled trial was conducted. A total of 150 women who were pregnant and had obesity were included. The intervention group received a complex combined digital intervention. The intervention was delivered with a smartband (Mi Band 2) linked to the app Mi Fit to measure PA and the Hangouts app with the midwife to provide personal health information. The control group received usual care. The validated Spanish versions of the International Physical Activity Questionnaire–Short Form and the System Usability Scale were used. Satisfaction was measured on a 1- to 5-point Likert scale. RESULTS: We analyzed 120 women, of whom 30 (25%) were withdrawn because of the COVID-19 pandemic. The median GWG in the intervention group was 7.0 (IQR 4-11) kg versus 9.3 (IQR 5.9-13.3) kg in the control group (P=.04). The adjusted mean GWG per week was 0.5 (95% CI 0.4-0.6) kg per week in the control group and 0.3 (95% CI 0.3-0.4) kg per week in the intervention group (df=0.1, 95% CI −0.2 to 0.03; P=.008). During the 35 and 37 gestational weeks, women in the intervention group had higher mean PA than women in the control group (1980 metabolic equivalents of tasks–minutes per week vs 1386 metabolic equivalents of tasks–minutes per week, respectively; P=.01). No differences were observed between the study groups in the incidence of maternal and perinatal outcomes. In the intervention group, 61% (36/59) of the women who were pregnant used the smartband daily, and 75% (44/59) evaluated the usability of the Mi Fit app as excellent. All women in the intervention group used the Hangouts app at least once a week. The mean of the satisfaction scale with the health counseling app and midwife support was 4.8/5 (SD 0.6) points. CONCLUSIONS: The use of a complex mobile health intervention was associated with adequate GWG, which was lower in the intervention group than in the control group. In addition, we observed that the intervention group had increases in PA. No differences were observed in maternal perinatal complications. TRIAL REGISTRATION: ClinicalTrials.gov NCT03706872; https://www.clinicaltrials.gov/ct2/show/NCT03706872

Manuscript tracking number * If this is a JMIR submission, please provide the manuscript tracking number under "other" (The ms tracking number can be found in the submission acknowledgement email, or when you login as author in JMIR. If the paper is already published in JMIR, then the ms tracking number is the four-digit number at the end of the DOI, to be found at the bottom of each published article in JMIR) 1a) Does your paper address CONSORT item 1a? * Identify the mode of delivery. Preferably use "web-based" and/or "mobile" and/or "electronic game" in the title. Avoid ambiguous terms like "online", "virtual", "interactive". Use "Internet-based" only if Intervention includes non-web-based Internet components (e.g. email), use "computer-based" or "electronic" only if orine products are used. Use "virtual" only in the context of "virtual reality" (3-D worlds). Use "online" only in the context of "online support groups". Complement or substitute product names with broader terms for the class of products (such as "mobile" or "smart phone" instead of "iphone"), especially if the application runs on different platforms.

Does your paper address subitem 1a-i? * Copy and paste relevant sections from manuscript title (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or briesy explain why the item is not applicable/relevant for your study "Effectiveness of a digital health intervention with a smartband and counselling App in gestational weight gain and physical activity in pregnant women with obesity (PAS & PES study): a randomised controlled trial"

Mention non-web-based components or important co-interventions in title, if any (e.g., "with telephone support"). Does your paper address subitem 1a-ii?

Copy and paste relevant sections from manuscript title (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or briesy explain why the item is not applicable/relevant for your study "with a smartband and counselling App "

1a-iii) Primary condition or target group in the title Mention primary condition or target group in the title, if any (e.g., "for children with Type I Diabetes") Example: A Web-based and Mobile Intervention with Telephone Support for Children with Type I Diabetes: Randomized Controlled Trial

Does your paper address subitem 1a-iii? * Copy and paste relevant sections from manuscript title (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or briesy explain why the item is not applicable/relevant for your study "in pregnant women with obesity"

subitem not at all important 

Does your paper address subitem 1b-i? * Copy and paste relevant sections from the manuscript abstract (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or briesy explain why the item is not applicable/relevant for your study "The intervention was delivered with a smartband (Mi band 2©) linked to the App Mi Fit© plus personalised health information and 24h/day midwife support through another App (Hangouts ©). Women in the control group (CG) only received standard antenatal care. "

Clarify the level of human involvement in the abstract, e.g., use phrases like "fully automated" vs. "therapist/nurse/care provider/physician-assisted" (mention number and expertise of providers involved, if any). (Note: Only report in the abstract what the main paper is reporting. If this information is missing from the main body of text, consider adding it) 13/4/21 19(50 CONSORT-EHEALTH (V 1.6.1) -Submission/Publication Form Página 13 de 63 https://docs.google.com/forms/d/e/1FAIpQLSfZBSUp1bwOc_Oimq…XpP_NdpOf03hmCqeZ73JVphtaPjK-1D00LeCz8V_TyIwIkcTAbBJUl_Bj8 subitem not at all important 1 2 3 4 5 essential Does your paper address subitem 1b-ii?

Copy and paste relevant sections from the manuscript abstract (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or briesy explain why the item is not applicable/relevant for your study "plus personalised health information and 24h/day midwife support through another App "

1b-iii) Open vs. closed, web-based (self-assessment) vs. face-to-face assessments in the METHODS section of the ABSTRACT Mention how participants were recruited (online vs. orine), e.g., from an open access website or from a clinic or a closed online user group (closed usergroup trial), and clarify if this was a purely webbased trial, or there were face-to-face components (as part of the intervention or for assessment). Clearly say if outcomes were self-assessed through questionnaires (as common in web-based trials 

Does your paper address subitem 1b-v?

Copy and paste relevant sections from the manuscript abstract (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or briesy explain why the item is not applicable/relevant for your study "The use of a smartband and a health counselling App together with virtual midwife support and standard prenatal controls were effective for obtaining a lower GWG and increasing the performance of PA in pregnant women with obesity. "

subitem not at all important 1 2 3 4 5 essential 2a-i) Problem and the type of system/solution

Describe the problem and the type of system/solution that is object of the study: intended as standalone intervention vs. incorporated in broader health care program? Intended for a particular patient population? Goals of the intervention, e.g., being more cost-effective to other interventions, replace or complement other solutions? (Note: Details about the intervention are provided in "Methods" under 5)

Does your paper address subitem 2a-i? * Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or briesy explain why the item is not applicable/relevant for your study "Pre-pregnancy obesity in Europe is estimated to be of 7.8% to 25.6% ", "Women presenting excessive gestational weight gain (GWG) have a higher probability of presenting complications [4] and this increases according to the class of obesity ", "According to Lau et al., 70% of pregnant women with overweight and/or obesity consulted a web page or used a mobile application to obtain information on adequate GWG ", "in the last years wearable devices such as wristbands have emerged", "few studies have analysed the impact of their use in pregnant women with pre-pregnancy obesity ".

subitem not at all important 

Does your paper address subitem 2a-ii? * Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or briesy explain why the item is not applicable/relevant for your study "Several intervention studies in pregnant women with overweight and/or pre-pregnancy obesity have exclusively used ICT with the sending of SMS, use of web platforms, social networks, telephone calls, Apps and pedometers. ICT have also been combined with in person interventions to promote lifestyles in pregnant women with obesity and/or overweight, obtaining heterogeneous results in GWG and PA ", "Despite the growing number of pregnant women consulting the internet or using smartbands during pregnancy, few studies have analysed the impact of their use in pregnant women with prepregnancy obesity [14] ." METHODS 3a) Description of trial design (such as parallel, factorial) including allocation ratio 3b) Impo"ant changes to methods a#er trial commencement (such as eligibility criteria), with reasons Does your paper address CONSORT subitem 2b? * Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or briesy explain why the item is not applicable/relevant for your study "The principal objective of this study was to evaluate the effectiveness of the use of a smartband and an App with health counselling together with virtual support from a midwife in relation to gestational weight gain and physical activity in pregnant women with pre-pregnancy obesity. The secondary objectives were to assess the impact of these interventions on maternal and perinatal outcomes as well as identify the frequency of use, usability and satisfaction with the mobile Apps used by the women in the intervention group."

Does your paper address CONSORT subitem 3a? * Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or briesy explain why the item is not applicable/relevant for your study "This randomised parallel controlled trial (PAS & PES) with two arms 1:1 (intervention and control group) was conducted in the Maternal-foetal Department of the Hospital Clinic of Barcelona from June 2018 to October 2020"

subitem not at all important 1 2 3 4 5 essential 4a) Eligibility criteria for pa"icipants Does your paper address CONSORT subitem 3b? * Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or briesy explain why the item is not applicable/relevant for your study "Any eligibility criteria were changes after trial."

Bug Pxes, Downtimes, Content Changes: ehealth systems are often dynamic systems. A description of changes to methods therefore also includes important changes made on the intervention or comparator during the trial (e.g., major bug Pxes or changes in the functionality or content) (5-iii) and other "unexpected events" that may have insuenced study design such as staff changes, system failures/downtimes, etc.

[2].

Does your paper address subitem 3b-i?

Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or briesy explain why the item is not applicable/relevant for your study "Any bug Pxes, downtimes, content were changes after trial." Does your paper address CONSORT subitem 4a? * Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or briesy explain why the item is not applicable/relevant for your study "Pregnant women with a pre-pregnancy BMI ≥ 30 Kg/m2 at 12 to 18 weeks of pregnancy, singleton pregnancy, ≥ 18 years of age, users of an Android smartphone or Iphone OS (IOS) with internet connection and who accepted to participate were included in the study. The exclusion criteria were pregnant women who already used an App for monitoring PA and weight or those with a previous diagnosis of a psychiatric or endocrine-metabolic disorder or chronic hypertension, pregnant women with a contraindication for performing exercise or mobility problems which do not allow moderate walking, or women with language dixculties for understanding Spanish"

Computer / Internet literacy is often an implicit "de facto" eligibility criterion -this should be explicitly clariPed.

Does your paper address subitem 4a-i?

Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or briesy explain why the item is not applicable/relevant for your study "No, we did not evaluate computer literacy". 4a-ii) Open vs. closed, web-based vs. face-to-face assessments:

Open vs. closed, web-based vs. face-to-face assessments: Mention how participants were recruited (online vs. orine), e.g., from an open access website or from a clinic, and clarify if this was a purely web-based trial, or there were face-to-face components (as part of the intervention or for assessment), i.e., to what degree got the study team to know the participant. In online-only trials, clarify if participants were quasi-anonymous and whether having multiple identities was possible or whether technical or logistical measures (e.g., cookies, email conPrmation, phone calls) were used to detect/prevent these.

Does your paper address subitem 4a-ii? * Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or briesy explain why the item is not applicable/relevant for your study "Usual prenatal care in the control and intervention groups....","Characteristic of the intervention in the intervention group: ..." Characteristic of the intervention in the control group ".

Information given during recruitment. Specify how participants were briefed for recruitment and in the informed consent procedures (e.g., publish the informed consent documentation as appendix, see also item X26), as this information may have an effect on user self-selection, user expectation and may also bias results. Does your paper address subitem 4a-iii?

Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or briesy explain why the item is not applicable/relevant for your study "Pregnant women attending hospital obstetric clinics and fulPlled the inclusion criteria were consecutively included in the study", "Randomisation:...."

Does your paper address CONSORT subitem 4b? *

Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or briesy explain why the item is not applicable/relevant for your study "Outcomes and data collection:..."

Clearly report if outcomes were (self-)assessed through online questionnaires (as common in webbased trials) or otherwise. 5) The interventions for each group with su%cient details to allow replication, including how and when they were actually administered Does your paper address subitem 4b-i? * Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or briesy explain why the item is not applicable/relevant for your study 

Does your paper address subitem 5-i?

Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or briesy explain why the item is not applicable/relevant for your study "Permission was obtained from the pertinent companies to use the Mi Band 2© smartband and the App linked to the wristband, Mi Fit © and the Hangouts © App for providing health advice and establishing 24-hour communication with the midwife. The source of information of the messages sent was extracted from the web page and Inatal © App. This is an interactive social web designed by gynaecologists and midwives from the Clinic Hospital from Barcelona. Permission was obtained for using the content. Video links for promoting physical activity and healthy eating habits of the web page of the "Health Department of Catalonia" were used as well as informative material from the "Catalan Midwives Association" available at their website." 

Describe the history/development process of the application and previous formative evaluations (e.g., focus groups, usability testing), as these will have an impact on adoption/use rates and help with interpreting results.

Does your paper address subitem 5-ii?

Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or briesy explain why the item is not applicable/relevant for your study "Characteristic of the intervention in the intervention group: ..."

Revisions and updating. Clearly mention the date and/or version number of the application/intervention (and comparator, if applicable) evaluated, or describe whether the intervention underwent major changes during the evaluation process, or whether the development and/or content was "frozen" during the trial. Describe dynamic components such as news feeds or changing content which may have an impact on the replicability of the intervention (for unexpected events see item 3b). Does your paper address subitem 5-iii?

Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or briesy explain why the item is not applicable/relevant for your study "This was not applicable in our study".

Provide information on quality assurance methods to ensure accuracy and quality of information provided [1], if applicable.

Does your paper address subitem 5-iv?

Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or briesy explain why the item is not applicable/relevant for your study "This was not applicable in our study". -v) Ensure replicability by publishing the source code, and/or providing screenshots/screen-capture video, and/or providing &owcha"s of the algorithms used Ensure replicability by publishing the source code, and/or providing screenshots/screen-capture video, and/or providing sowcharts of the algorithms used. Replicability (i.e., other researchers should in principle be able to replicate the study) is a hallmark of scientiPc reporting.

Does your paper address subitem 5-v?

Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or briesy explain why the item is not applicable/relevant for your study "This was not applicable in our study".

Digital preservation: Provide the URL of the application, but as the intervention is likely to change or disappear over the course of the years; also make sure the intervention is archived (Internet Archive, webcitation.org, and/or publishing the source code or screenshots/videos alongside the article). As pages behind login screens cannot be archived, consider creating demo pages which are accessible without login.

13/4/21 19(50 CONSORT-EHEALTH (V 1.6.1) -Submission/Publication Form Does your paper address subitem 5-vi?

Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or briesy explain why the item is not applicable/relevant for your study "This was not applicable in our study".

Access: Describe how participants accessed the application, in what setting/context, if they had to pay (or were paid) or not, whether they had to be a member of speciPc group. If known, describe how participants obtained "access to the platform and Internet" [1]. To ensure access for editors/reviewers/readers, consider to provide a "backdoor" login account or demo mode for reviewers/readers to explore the application (also important for archiving purposes, see vi).

Does your paper address subitem 5-vii? * Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or briesy explain why the item is not applicable/relevant for your study "After the participant had been assigned to the IG, ... and explained that it should be worn during the day.", "The smartband was linked to the Mi Fit © App, this App was free and available for Android and IOS systems. The midwife instructed the pregnant woman on how to set up the step and weight goals through notiPcations of goals and activated alerts in the App so that the smartband would vibrate during prolonged times of inactivity or would send prizes when goals were achieved. ", "If necessary the midwife .... could receive personalised information through text messages or videos sent by the research team twice a week.","the research team asked the pregnant women about their current weight and motivated or reinforced their progress through a monthly chat of the Hangouts ©App. ", "the pregnant women could consult about doubts which the research team solved with an immediate response (< 1 hour). ". 

Does your paper address subitem 5-viii? * Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or briesy explain why the item is not applicable/relevant for your study "After the participant had been assigned to the IG, ... and explained that it should be worn during the day.", "The smartband was linked to the Mi Fit © App, this App was free and available for Android and IOS systems. The midwife instructed the pregnant woman on how to set up the step and weight goals through notiPcations of goals and activated alerts in the App so that the smartband would vibrate during prolonged times of inactivity or would send prizes when goals were achieved. ", "If necessary the midwife .... could receive personalised information through text messages or videos sent by the research team twice a week.","the research team asked the pregnant women about their current weight and motivated or reinforced their progress through a monthly chat of the Hangouts ©App. ", "the pregnant women could consult about doubts which the research team solved with an immediate response (< 1 hour). ". 

Describe use parameters (e.g., intended "doses" and optimal timing for use). Clarify what instructions or recommendations were given to the user, e.g., regarding timing, frequency, heaviness of use, if any, or was the intervention used ad libitum.

Does your paper address subitem 5-ix?

Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or briesy explain why the item is not applicable/relevant for your study "After the participant had been assigned to the IG, ... and explained that it should be worn during the day.", "The smartband was linked to the Mi Fit © App, this App was free and available for Android and IOS systems. The midwife instructed the pregnant woman on how to set up the step and weight goals through notiPcations of goals and activated alerts in the App so that the smartband would vibrate during prolonged times of inactivity or would send prizes when goals were achieved. ", "If necessary the midwife .... could receive personalised information through text messages or videos sent by the research team twice a week.","the research team asked the pregnant women about their current weight and motivated or reinforced their progress through a monthly chat of the Hangouts ©App. ", "the pregnant women could consult about doubts which the research team solved with an immediate response (< 1 hour). ". 

Clarify the level of human involvement (care providers or health professionals, also technical assistance) in the e-intervention or as co-intervention (detail number and expertise of professionals involved, if any, as well as "type of assistance offered, the timing and frequency of the support, how it is initiated, and the medium by which the assistance is delivered". It may be necessary to distinguish between the level of human involvement required for the trial, and the level of human involvement required for a routine application outside of a RCT setting (discuss under item 21 -generalizability).

Does your paper address subitem 5-x?

Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or briesy explain why the item is not applicable/relevant for your study "After the participant had been assigned to the IG, ... and explained that it should be worn during the day.", "The smartband was linked to the Mi Fit © App, this App was free and available for Android and IOS systems. The midwife instructed the pregnant woman on how to set up the step and weight goals through notiPcations of goals and activated alerts in the App so that the smartband would vibrate during prolonged times of inactivity or would send prizes when goals were achieved. ", "If necessary the midwife .... could receive personalised information through text messages or videos sent by the research team twice a week.","the research team asked the pregnant women about their current weight and motivated or reinforced their progress through a monthly chat of the Hangouts ©App. ", "the pregnant women could consult about doubts which the research team solved with an immediate response (< 1 hour). ". 

Does your paper address subitem 5-xi? * Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or briesy explain why the item is not applicable/relevant for your study "the research team asked the pregnant women about their current weight and motivated or reinforced their progress through a monthly chat of the Hangouts ©App. "

Describe any co-interventions (incl. training/support): Clearly state any interventions that are provided in addition to the targeted eHealth intervention, as ehealth intervention may not be designed as standalone intervention. This includes training sessions and support [1]. It may be necessary to distinguish between the level of training required for the trial, and the level of training for a routine application outside of a RCT setting (discuss under item 21 -generalizability. 6a-ii) Describe whether and how "use" (including intensity of use/dosage) was de%ned/measured/monitored Describe whether and how "use" (including intensity of use/dosage) was dePned/measured/monitored (logins, logPle analysis, etc.). Use/adoption metrics are important process outcomes that should be reported in any ehealth trial.

Does your paper address subitem 6a-ii?

Copy and paste relevant sections from manuscript text "After the participant had been assigned to the IG, ... and explained that it should be worn during the day.", "The smartband was linked to the Mi Fit © App, this App was free and available for Android and IOS systems. The midwife instructed the pregnant woman on how to set up the step and weight goals through notiPcations of goals and activated alerts in the App so that the smartband would vibrate during prolonged times of inactivity or would send prizes when goals were achieved. ", "If necessary the midwife .... could receive personalised information through text messages or videos sent by the research team twice a week.","the research team asked the pregnant women about their current weight and motivated or reinforced their progress through a monthly chat of the Hangouts ©App. ", "the pregnant women could consult about doubts which the research team solved with an immediate response (< 1 hour). ". subitem not at all important 1 2 3 4 5 essential 6b) Any changes to trial outcomes a#er the trial commenced, with reasons 7a) How sample size was determined NPT: When applicable, details of whether and how the clustering by care provides or centers was addressed 6a-iii) Describe whether, how, and when qualitative feedback from pa"icipants was obtained

Describe whether, how, and when qualitative feedback from participants was obtained (e.g., through emails, feedback forms, interviews, focus groups).

Does your paper address subitem 6a-iii?

Copy and paste relevant sections from manuscript text "the research team asked the pregnant women about their current weight and motivated or reinforced their progress through a monthly chat of the Hangouts ©App. ", "Through this App, the pregnant women could consult about doubts which the research team solved with an immediate response (< 1 hour). "

Does your paper address CONSORT subitem 6b? * Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or briesy explain why the item is not applicable/relevant for your study "Does not apply in our study." subitem not at all important 1 2 3 4 5 essential 7b) When applicable, explanation of any interim analyses and stopping guidelines 7a-i) Describe whether and how expected a'rition was taken into account when calculating the sample size Describe whether and how expected attrition was taken into account when calculating the sample size.

Does your paper address subitem 7a-i?

Copy and paste relevant sections from manuscript title (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or briesy explain why the item is not applicable/relevant for your study "The calculation of sample size was based on the variable of weight gain to detect a difference ≥ 3.4 kg (SD: 7.1) [18] . An α risk of 0.05 and a β risk of 0.2 were accepted in the bilateral contrast. It was calculated that 81 women were needed in the IG and 81 in the CG. A loss to follow-up of 20% was estimated. "

Does your paper address CONSORT subitem 7b? * Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or briesy explain why the item is not applicable/relevant for your study "Does not apply in our study" 13/4/21 19(50 CONSORT-EHEALTH (V 1.6.1) -Submission/Publication Form Página 37 de 63 https://docs.google.com/forms/d/e/1FAIpQLSfZBSUp1bwOc_Oimq…XpP_NdpOf03hmCqeZ73JVphtaPjK-1D00LeCz8V_TyIwIkcTAbBJUl_Bj8 8a) Method used to generate the random allocation sequence NPT: When applicable, how care providers were allocated to each trial group 8b) Type of randomisation; details of any restriction (such as blocking and block size) Does your paper address CONSORT subitem 8a? * Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or briesy explain why the item is not applicable/relevant for your study "Randomisation was computer based. Two random number lists were created by the University of Barcelona and opaque numbered envelopes were prepared to mask group assignment. After the study participant had been informed about the study and accepted and signed the informed consent, the midwife opened the opaque and sealed envelope, and the pregnant woman was assigned to either the intervention (IG) or control group (CG)."

Does your paper address CONSORT subitem 8b? * Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or briesy explain why the item is not applicable/relevant for your study "Randomisation was computer based. Two random number lists were created by the University of Barcelona and opaque numbered envelopes were prepared to mask group assignment. After the study participant had been informed about the study and accepted and signed the informed consent, the midwife opened the opaque and sealed envelope, and the pregnant woman was assigned to either the intervention (IG) or control group (CG)." 9) Mechanism used to implement the random allocation sequence (such as sequentially numbered containers), describing any steps taken to conceal the sequence until interventions were assigned 10) Who generated the random allocation sequence, who enrolled pa"icipants, and who assigned pa"icipants to interventions Does your paper address CONSORT subitem 9? * Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or briesy explain why the item is not applicable/relevant for your study "Randomisation was computer based. Two random number lists were created by the University of Barcelona and opaque numbered envelopes were prepared to mask group assignment. After the study participant had been informed about the study and accepted and signed the informed consent, the midwife opened the opaque and sealed envelope, and the pregnant woman was assigned to either the intervention (IG) or control group (CG)." Does your paper address CONSORT subitem 10? * Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or briesy explain why the item is not applicable/relevant for your study "Randomisation was computer based. Two random number lists were created by the University of Barcelona and opaque numbered envelopes were prepared to mask group assignment. After the study participant had been informed about the study and accepted and signed the informed consent, the midwife opened the opaque and sealed envelope, and the pregnant woman was assigned to either the intervention (IG) or control group (CG)." 11a) If done, who was blinded a#er assignment to interventions (for example, pa"icipants, care providers, those assessing outcomes) and how NPT: Whether or not administering co-interventions were blinded to group assignment subitem not at all important 1 2 3 4 5 essential subitem not at all important 1 2 3 4 5 essential 11a-i) Specify who was blinded, and who wasn't Specify who was blinded, and who wasn't. Usually, in web-based trials it is not possible to blind the participants [1, 3] (this should be clearly acknowledged), but it may be possible to blind outcome assessors, those doing data analysis or those administering co-interventions (if any).

Does your paper address subitem 11a-i? * Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or briesy explain why the item is not applicable/relevant for your study "Blinded was not apply in our study"

11a-ii) Discuss e.g., whether pa"icipants knew which intervention was the "intervention of interest" and which one was the "comparator"

Informed consent procedures (4a-ii) can create biases and certain expectations -discuss e.g., whether participants knew which intervention was the "intervention of interest" and which one was the "comparator".

(this item is usually not relevant for ehealth trials as it refers to similarity of a placebo or sham intervention to a active medication/intervention) 12a) Statistical methods used to compare groups for primary and secondary outcomes NPT: When applicable, details of whether and how the clustering by care providers or centers was addressed Does your paper address subitem 11a-ii?

Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or briesy explain why the item is not applicable/relevant for your study "Blinded was not apply in our study"

Does your paper address CONSORT subitem 11b? * Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or briesy explain why the item is not applicable/relevant for your study "Does not apply in our study" Does your paper address CONSORT subitem 12a? * Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or briesy explain why the item is not applicable/relevant for your study "The analyses were performed on an intention to treat basis according to the treatment group allocated at randomisation. Descriptive data are presented as number and percentage and the mean and standard deviation (SD) and the median and quartile 1 and quartile 3 (Q1-Q3). Bivariate analysis was performed between the socio-demographic variables and the pre-pregnancy BMI. For the comparison of the categorical variables, the Chi-Square or the Fisher exact test was used. To compare quantitative variables, the Student's t, Mann-Whitney U or Wilcoxon test was performed. Multinomial logistic regression was used to analyse the association between total PA at the end of the study (low, moderate, and high) and age and BMI at recruitment, parity (yes, no), and test group (control, intervention). Adjusted Odds Ratio (OR) and 95% conPdence intervals (95%CI) were calculated for each model.

To evaluate the effect of the intervention on weight gain per week (kg/week) of the participants at the end of the study, the linear regression model was used adjusted for age and BMI at recruitment, parity (yes, no), and total PA at the end of the study (low, moderate, and high). All statistical tests were two-sided and evaluated at α-level of 0.05. Analyses were performed using SPSS v. 25 and SAS v. 9.4."

Imputation techniques to deal with attrition / missing values: Not all participants will use the intervention/comparator as intended and attrition is typically high in ehealth trials. Specify how participants who did not use the application or dropped out from the trial were treated in the statistical analysis (a complete case analysis is strongly discouraged, and simple imputation techniques such as LOCF may also be problematic [4]).

Does your paper address subitem 12a-i? * Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or briesy explain why the item is not applicable/relevant for your study "Does not apply in our study"

Does your paper address CONSORT subitem 12b? * Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or briesy explain why the item is not applicable/relevant for your study "Multinomial logistic regression was used to analyse the association between total PA at the end of the study (low, moderate, and high) and age and BMI at recruitment, parity (yes, no), and test group (control, intervention). Adjusted Odds Ratio (OR) and 95% conPdence intervals (95%CI) were calculated for each model. To evaluate the effect of the intervention on weight gain per week (kg/week) of the participants at the end of the study, the linear regression model was used adjusted for age and BMI at recruitment, parity (yes, no), and total PA at the end of the study (low, moderate, and high). All statistical tests were two-sided and evaluated at α-level of 0.05." 

Does your paper address subitem X26-ii?

Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or briesy explain why the item is not applicable/relevant for your study "Informed consent was obtained from all the participants.", "All the participants provided written informed consent"

Safety and security procedures, incl. privacy considerations, and any steps taken to reduce the likelihood or detection of harm (e.g., education and training, availability of a hotline)

Does your paper address subitem X26-iii?

Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or briesy explain why the item is not applicable/relevant for your study "No information regarding data or results in the clinical history of the woman was presented through this App ", "The anonymity and conPdentiality of the data were always preserved in accordance with the Spanish Organic Law 3/2018, of December 5, on the Protection of Personal Data and guarantee of digital rights. Informed consent was obtained from all the participants." 1 2 3 4 5 essential 14a) Dates de!ning the periods of recruitment and follow-up

Strongly recommended: An attrition diagram (e.g., proportion of participants still logging in or using the intervention/comparator in each group plotted over time, similar to a survival curve) or other Pgures or tables demonstrating usage/dose/engagement.

Does your paper address subitem 13b-i?

Copy and paste relevant sections from the manuscript or cite the Pgure number if applicable (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or briesy explain why the item is not applicable/relevant for your study " Figure 1 shows Does your paper address CONSORT subitem 14a? * Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or briesy explain why the item is not applicable/relevant for your study " Figure 1 shows the sow diagram of the recruitment of study participants according to the recommendation of the Consolidated Standards of Reporting Trials (CONSORT) Statement", "The COVID-19 pandemic in Spain led to strict home conPnement which interfered with PA and the prenatal care received by the participants. Therefore, on April 1, 2020, 30 women who had not reached 35 weeks of pregnancy were withdrawn from the study. At T1 120/150 women were analysed, and variables related to delivery and the neonate of 115/150 women were analysed (Pgure 2)."

Indicate if critical "secular events" fell into the study period, e.g., signiPcant changes in Internet resources available or "changes in computer hardware or Internet delivery resources"

Does your paper address subitem 14a-i?

Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or briesy explain why the item is not applicable/relevant for your study "Does not apply in our study" Does your paper address CONSORT subitem 14b? * Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or briesy explain why the item is not applicable/relevant for your study "The COVID-19 pandemic in Spain led to strict home conPnement which interfered with PA and the prenatal care received by the participants. Therefore, on April 1, 2020, 30 women who had not reached 35 weeks of pregnancy were withdrawn from the study. At T1 120/150 women were analysed, and variables related to delivery and the neonate of 115/150 women were analysed (Pgure 2)."

Does your paper address CONSORT subitem 15? * Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or briesy explain why the item is not applicable/relevant for your study "The basal characteristics of the study participants are shown in table 1. "

In ehealth trials it is particularly important to report demographics associated with digital divide issues, such as age, education, gender, social-economic status, computer/Internet/ehealth literacy of the participants, if known.

16) For each group, number of pa"icipants (denominator) included in each analysis and whether the analysis was by original assigned groups subitem not at all important 1 2 3 4 5 essential Does your paper address subitem 15-i? * Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or briesy explain why the item is not applicable/relevant for your study "Does not apply in our study"

Report multiple "denominators" and provide dePnitions: Report N's (and effect sizes) "across a range of study participation [and use] thresholds" [1], e.g., N exposed, N consented, N used more than x times, N used more than y weeks, N participants "used" the intervention/comparator at speciPc pre-dePned time points of interest (in absolute and relative numbers per group). Always clearly dePne "use" of the intervention.

Does your paper address subitem 16-i? * Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or briesy explain why the item is not applicable/relevant for your study "The basal characteristics of the study participants are shown in 17a) For each primary and secondary outcome, results for each group, and the estimated e&ect size and its precision (such as 95% con!dence interval)

Primary analysis should be intent-to-treat, secondary analyses could include comparing only "users", with the appropriate caveats that this is no longer a randomized sample (see 18-i).

Does your paper address subitem 16-ii?

Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or briesy explain why the item is not applicable/relevant for your study "The analyses were performed on an intention to treat basis according to the treatment group allocated at randomisation."

Does your paper address CONSORT subitem 17a? * Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or briesy explain why the item is not applicable/relevant for your study "The analyses were performed on an intention to treat basis according to the treatment group allocated at randomisation", "Adjusted Odds Ratio (OR) and 95% conPdence intervals (95%CI) were calculated for each model.", "All statistical tests were two-sided and evaluated at α-level of 0.05". In addition to primary/secondary (clinical) outcomes, the presentation of process outcomes such as metrics of use and intensity of use (dose, exposure) and their operational dePnitions is critical. This does not only refer to metrics of attrition (13-b) (often a binary variable), but also to more continuous exposure metrics such as "average session length". These must be accompanied by a technical description how a metric like a "session" is dePned (e.g., timeout after idle time) [1] (report under item 6a).

Does your paper address subitem 17a-i?

Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or briesy explain why the item is not applicable/relevant for your study "Does not apply in our study"

Does your paper address CONSORT subitem 17b? * Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or briesy explain why the item is not applicable/relevant for your study "Bivariate analysis was performed between the socio-demographic variables and the prepregnancy BMI. For the comparison of the categorical variables, the Chi-Square or the Fisher exact test was used. To compare quantitative variables, the Student's t, Mann-Whitney U or Wilcoxon test was performed. "

18) Results of any other analyses pe'ormed, including subgroup analyses and adjusted analyses, distinguishing pre-speci!ed from exploratory subitem not at all important 1 2 3 4 5 essential Does your paper address CONSORT subitem 18? * Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or briesy explain why the item is not applicable/relevant for your study "The COVID-19 pandemic in Spain led to strict home conPnement which interfered with PA and the prenatal care received by the participants", "In addition, an elevated number of pregnant women who were conPned at home during the Prst wave of the pandemic had to be withdrawn from the analysis of the study since we considered that this could insuence the results (30/150). Nonetheless, these women continued in the study and the results obtained are pending publication.", "However, multinominal models were performed to adjust the effect of the intervention on the weight gain variables and PA by categories"

A subgroup analysis of comparing only users is not uncommon in ehealth trials, but if done, it must be stressed that this is a self-selected sample and no longer an unbiased sample from a randomized trial (see 16-iii).

(for speciPc guidance see CONSORT for harms) Does your paper address subitem 18-i?

Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or briesy explain why the item is not applicable/relevant for your study "The COVID-19 pandemic in Spain led to strict home conPnement which interfered with PA and the prenatal care received by the participants", "In addition, an elevated number of pregnant women who were conPned at home during the Prst wave of the pandemic had to be withdrawn from the analysis of the study since we considered that this could insuence the results (30/150). Nonetheless, these women continued in the study and the results obtained are pending publication.", "However, multinominal models were performed to adjust the effect of the intervention on the weight gain variables and PA by categories"

Does your paper address CONSORT subitem 19? * Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or briesy explain why the item is not applicable/relevant for your study "None of the women showed adverse effects with the use of the smartband" 

Does your paper address subitem 19-i?

Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or briesy explain why the item is not applicable/relevant for your study "None of the women showed adverse effects with the use of the smartband" "No information regarding data or results in the clinical history of the woman was presented through this App ", "The anonymity and conPdentiality of the data were always preserved in accordance with the Spanish Organic Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or briesy explain why the item is not applicable/relevant for your study "and the satisfaction of the women who received health counselling and virtual midwife support evaluated with 6 questions answered using a 1 to 5 Likert scale in which 1 was not at all satisPed and 5 was very satisPed. The questionnaires were anonymously selfreported by the pregnant women between 35 and 37 weeks of pregnancy. "

22-i) Restate study questions and summarize the answers suggested by the data, sta"ing with primary outcomes and process outcomes (use)

Restate study questions and summarize the answers suggested by the data, starting with primary outcomes and process outcomes (use). Does your paper address subitem 22-i? * Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or briesy explain why the item is not applicable/relevant for your study "The Pndings of this study show that the use of a complex digital intervention was associated with lower GWG and an increase of PA during pregnancy in pregnant women with obesity, but there were no differences in the incidence of maternal and perinatal complications between the two study groups. All the women in the IG used the smartband and the health counselling App at least once a week. In addition, the usability of the App linked to the smartband was evaluated as excellent, and the grade of overall satisfaction with the health counselling App and support by the virtual midwife was very high. "

Highlight unanswered new questions, suggest future research.

Does your paper address subitem 22-ii?

Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or briesy explain why the item is not applicable/relevant for your study "Further clinical studies in larger samples of pregnant women with pre-pregnancy obesity are necessary to evaluate the effectiveness and feasibility of the use of new technologies during pregnancy and their insuence on maternal and perinatal health" 

Typical limitations in ehealth trials: Participants in ehealth trials are rarely blinded. Ehealth trials often look at a multiplicity of outcomes, increasing risk for a Type I error. Discuss biases due to non-use of the intervention/usability issues, biases through informed consent procedures, unexpected events.

Does your paper address subitem 20-i? * Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or briesy explain why the item is not applicable/relevant for your study "A limitation of the study is that the estimated sample size could not be achieved (150/162 pregnant women) due to the COVID-19 pandemic. In addition, an elevated number of pregnant women who were conPned at home during the Prst wave of the pandemic had to be withdrawn from the analysis of the study since we considered that this could insuence the results (30/150). ...The data collected by the application linked to the smartband in relation to the number of steps or physical activity performed by the pregnant women in the IG was not monitored since the objective of the study was to compare the PA between the two groups at T0 and T1. We used a validated questionnaire self-reported by the participants and this may have induced a memory bias with underestimated/overestimated reporting by the women [50,51]. " 

Generalizability to other populations: In particular, discuss generalizability to a general Internet population, outside of a RCT setting, and general patient population, including applicability of the study results for other organizations

Does your paper address subitem 21-i?

Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or briesy explain why the item is not applicable/relevant for your study "The results of the present study demonstrate that the use of a smartband and an App for providing health counselling and virtual support from a midwife during pregnancy in pregnant women with obesity is effective and safe and can be applied to promote healthy lifestyles in prenatal control", "It would also be useful to provide evidence-based information and resolve doubts from a distance since health professionals have described dixculties in the management of GWG in pregnant women with obesity and a lack of time in the consultation [48] . Likewise, telematics access provides the opportunity for professionals to gain access to a greater population, even to pregnant women who less frequently attend healthcare centres. In addition, providing information through Apps provides quality and safety in the care of women during pregnancy and contributes to reducing the heterogeneity of information regarding health and pregnancy which pregnant women see on the internet [49]." Discuss if there were elements in the RCT that would be different in a routine application setting (e.g., prompts/reminders, more human involvement, training sessions or other co-interventions) and what impact the omission of these elements could have on use, adoption, or outcomes if the intervention is applied outside of a RCT setting.

Does your paper address subitem 21-ii?

Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or briesy explain why the item is not applicable/relevant for your study "It would also be useful to provide evidence-based information and resolve doubts from a distance since health professionals have described dixculties in the management of GWG in pregnant women with obesity and a lack of time in the consultation" X27) Con(icts of Interest (not a CONSORT item)

subitem not at all important 1 2 3 4 5 essential About the CONSORT EHEALTH checklist yes, major changes yes, minor changes no X27-i) State the relation of the study team towards the system being evaluated

In addition to the usual declaration of interests (Pnancial or otherwise), also state the relation of the study team towards the system being evaluated, i.e., state if the authors/evaluators are distinct from or identical with the developers/sponsors of the intervention.

Does your paper address subitem X27-i?

Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or briesy explain why the item is not applicable/relevant for your study "Consicts of interest. None declared"

As a result of using this checklist, did you make changes in your manuscript? *

Does your paper address CONSORT subitem 24? * Cite a Multimedia Appendix, other reference, or copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or briesy explain why the item is not applicable/relevant for your study "Trial registration. This trial was registered in the Clinical Trial Register of the National Library of Medicine of United States (NCT03706872)